4.5 Article

Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure

Journal

JACC-HEART FAILURE
Volume 9, Issue 4, Pages 293-300

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2020.12.006

Keywords

heart failure; splanchnic nerve block; stressed blood volume; sympathetic nervous system; congestion

Funding

  1. American Heart Association (AHA) [17MCPRP33460225]
  2. American Heart Association [17MCPRP33460225]
  3. National Institutes of Health (NIH) [5T32HL007101]
  4. Mario Family Award
  5. HeartFlow
  6. Bayer
  7. Janssen
  8. National Heart, Lung, and Blood Institute (NHLBI)
  9. National Institutes of Health (NIH) /National Heart, Lung, and Blood Institute (NHLBI) [R01 HL128526, U0 1 HL125205]
  10. Translating Duke Health Award
  11. AstraZeneca
  12. Corvia
  13. Medtronic
  14. Mesoblast
  15. GlaxoSmithKline
  16. TENAX
  17. American Heart Association
  18. Amgen
  19. IntraCellular Therapies
  20. American Regent, Inc.
  21. NHLBI
  22. Novartis
  23. PCORI
  24. BristolMyers Squibb
  25. AHA
  26. Cytokinetics
  27. Merck
  28. Abiomed
  29. Ancora Heart
  30. Tenax Therapeutics
  31. Fire 1
  32. Abbott
  33. American Regent
  34. Boehringer Ingelheim/Eli Lilly
  35. Boston Scientific
  36. Fast BioMedical
  37. Gilead
  38. Roche
  39. Sanofi
  40. Vifor

Ask authors/readers for more resources

The study analyzed data from two prospective clinical studies on decompensated HFrEF and ambulatory heart failure patients. The results showed that splanchnic nerve block decreased the estimated stressed blood volume in decompensated HFrEF patients, while it increased in ambulatory HFrEF patients.
METHODS We analyzed data from 2 prospective, single-arm clinical studies in decompensated HFrEF (splanchnic HF-1; resting hemodynamics) and ambulatory heart failure (splanchnic HF-2; exercise hemodynamics). Patients underwent invasive hemodynamics and short-term SNB with local anesthetics. SBV was simulated using heart rate, cardiac output, central venous pressure, pulmonary capillary wedge pressure, systolic and diastolic systemic arterial and pulmonary artery pressures, and left ventricular ejection fraction. SBV is presented as ml/70 kg body weight. OBJECTIVES The authors estimated changes of stressed blood volume (SBV) induced by splanchnic nerve block (SNB) in patients with either decompensated or ambulatory heart failure with reduced ejection fraction (HFrEF). BACKGROUND The splanchnic vascular capacity is a major determinant of the SBV, which in turn determines cardiac filling pressures and may be modifiable through SNB. METHODS We analyzed data from 2 prospective, single-arm clinical studies in decompensated HFrEF (splanchnic HF-1; resting hemodynamics) and ambulatory heart failure (splanchnic HF-2; exercise hemodynamics). Patients underwent invasive hemodynamics and short-term SNB with local anesthetics. SBV was simulated using heart rate, cardiac output, central venous pressure, pulmonary capillary wedge pressure, systolic and diastolic systemic arterial and pulmonary artery pressures, and left ventricular ejection fraction. SBV is presented as ml/70 kg body weight. RESULTS Mean left ventricular ejection fraction was 21 +/- 11%. In patients with decompensated HFrEF (n = 11), the mean estimated SBV was 3,073 +/- 251 ml/70 kg. At 30 min post-SNB, the estimated SBV decreased by 10% to 2,754 +/- 386 ml/70 kg (p = 0.003). In ambulatory HFrEF (n = 14) patients, the mean estimated SBV was 2,664 +/- 488 ml/70 kg and increased to 3,243 +/- 444 ml/70 kg (p < 0.001) at peak exercise. The resting estimated SBV was lower in ambulatory patients with HFrEF than in decompensated HFrEF (p = 0.019). In ambulatory patients with HFrEF, post-SNB, the resting estimated SBV decreased by 532 +/- 264 ml/70 kg (p < 0.001). Post-SNB, with exercise, there was no decrease of estimated SBV out of proportion to baseline effects (p = 0.661). CONCLUSIONS The estimated SBV is higher in decompensated than in ambulatory heart failure. SNB reduced the estimated SBV in decompensated and ambulatory heart failure. The reduction in estimated SBV was maintained throughout exercise. (Splanchnic Nerve Anesthesia in Heart Failure, NCT02669407; Abdominal Nerve Blockade in Chronic Heart Failure, NCT03453151) (J Am Coll Cardiol HF 2021;9:293-300) (c) 2021 by the American College of Cardiology Foundation. RESULTS Mean left ventricular ejection fraction was 21 ? 11%. In patients with decompensated HFrEF (n = 11), the mean estimated SBV was 3,073 ? 251 ml/70 kg. At 30 min post-SNB, the estimated SBV decreased by 10% to 2,754 ? 386 ml/70 kg (p = 0.003). In ambulatory HFrEF (n = 14) patients, the mean estimated SBV was 2,664 ? 488 ml/70 kg and increased to 3,243 ? 444 ml/70 kg (p < 0.001) at peak exercise. The resting estimated SBV was lower in ambulatory patients with HFrEF than in decompensated HFrEF (p = 0.019). In ambulatory patients with HFrEF, post-SNB, the resting estimated SBV decreased by 532 ? 264 ml/70 kg (p < 0.001). Post-SNB, with exercise, there was no decrease of esti

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available